FMR CORP 13D/13G Filings for Intellia Therapeutics, Inc. (NTLA)

FMR CORP 13D and 13G filings for Intellia Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-09
11:18 am
Sale
2023-02-09 13G Intellia Therapeutics, Inc.
NTLA
FMR CORP 2,421,952
2.879%
-1,455,820decrease
(-37.54%)
Filing
2022-02-09
09:19 am
Purchase
2022-02-08 13G Intellia Therapeutics, Inc.
NTLA
FMR CORP 3,877,772
5.210%
3,719,166increase
(+2344.91%)
Filing